mild to moderate psoriasis
Mild-to-Moderate Psoriasis
$273.00 Original price was: $273.00.$4.99Current price is: $4.99. Add to cart
Sale!

Mild-to-Moderate Psoriasis

Original price was: $273.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

Beyond the Surface: Mild-to-Moderate Psoriasis

While severe, full-body psoriasis commands immediate, aggressive systemic therapy, the vast majority of patients suffer from “mild-to-moderate” disease. This label is clinically deceptive; a few strategically placed plaques on the hands, scalp, or genitals can cause excruciating pain, profound social isolation, and devastating psychological distress. Mild-to-Moderate Psoriasis is the definitive, fiercely practical text dedicated entirely to managing this specific, often underserved patient population. This volume provides the exact blueprints required by dermatologists to optimize topical therapies and improve quality of life without exposing the patient to the risks of heavy immunosuppression.

Mastering Targeted Topical Therapy

The core philosophy of this text is maximizing localized control. The authors aggressively detail the strategic use of high-potency topical corticosteroids, vitamin D analogues (calcipotriene), and calcineurin inhibitors. It dictates exactly how to design combination regimens and rotational therapy schedules to maximize efficacy while definitively preventing the devastating complication of steroid-induced skin atrophy.

Navigating Difficult Anatomical Sites

The book provides a masterclass in localized management. It dictates the exact clinical pathways for treating psoriasis in notoriously difficult areas: the scalp (requiring specific vehicle formulations like foams or shampoos), the nails (which often presage psoriatic arthritis), and the intertriginous/genital regions (where standard potent steroids are absolutely contraindicated).

Frequently Asked Questions (FAQs)

Does this book address when to escalate to biologics?
Yes, it features critical chapters defining the precise tipping point—such as severe recalcitrance to topicals or profound psychological impact—where a “mild” BSA (Body Surface Area) score still mandates systemic biologic therapy.

Who is the primary audience?
It is the absolute, mandatory clinical guide for Dermatologists, General Practitioners, Dermatology Nurse Practitioners, and Physician Assistants.